Open access
Aug 2026
Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) constitute a clinico‐genetic‐neuropathological continuum with marked heterogeneity. Reliable in vivo biomarkers of the disease are lacking. Large, multimodal cohorts are needed to advance biomarker discovery and precision medicine.
Á. Carbayo, J. Turon-Sans, D. Alcolea et al.
· Alzheimer's & Dementia · 0 citations